baber/WOPTO huggingface dataset:
Patent PE-20210611-Z (PE)
Title: Dispositivo inyector mejorado para el inflado de pernos expansivos
Inventor: CORDERO CARHUAMANCA ALBINO RICHARD
IPC: A61M5/28
Filed: 2020-10-16
Abstract: La presente invencion se refiere a un dispositivo de Inyeccion para el inflado de pernos expansivos que se desarrolla en el campo dedicado a la Industria de la Mineria, en particular a los accesorios de los equipos de perforacion. El dispositivo de inyeccion para el inflado de pernos expansivos es del tipo que comprende un cabezal de inyeccion (1) acoplado por su parte posterior a un adaptador para su montaje a un equipo de perforacion que ademas comprende una tuerca moleteada (14) acoplada a la parte delantera del cabezal de inyeccion (1) donde dicha tuerca moleteada (14) tiene un vaciado (14b) de forma conica en su parte frontal para guiar y centrar al perno expansivo. Se proporcionan ademas una serie de mejoras en la configuracion del cabezal de inyeccion (1). Los efectos beneficiosos de la invencion son que brinda la facilidad de forma manual para su ajuste, ademas de que reduce las perdidas de presion ocasionadas normalmente por la fugas y por ende, el llenado del perno expansivo es mas rapido.
Patent ES-499054-A0 (ES)
IPC: C12N15/00
Filed: 1981-02-03
Abstract: The process for the preparation of the polypeptide which contains the amino-acid sequence of the proinsulin of primates entails the genetic information for the biosynthesis of the said polypeptide being obtained by means of mRNA from primates, the cDNA being prepared therefrom and inserted into a plasmid, the resulting hybrid plasmid being used to transform microorganisms, and the microorganisms producing the polypeptide being obtained by selection and cultivation.
Patent ES-530653-A0 (ES)
IPC: C07D491/04
Filed: 1984-03-15
Abstract: The present invention relates to novel N-oxide compounds that have cardiovascular properties, especially antihypertensive activity, and that correspond to the formula    <IMAGE>  (I)  in which Py represents an unsubstituted or substituted N-oxidopyridyl radical, R1 represents hydrogen or unsubstituted or substituted lower alkyl, one of the radicals R2 and R3 represents lower alkyl and the other represents hydrogen; lower alkyl; lower alkyl containing free, etherified or esterified hydroxy, oxo, functionally modified carboxy or free or substituted amino or imino; functionally modified carboxy; or free or substituted amino, it being possible for an amino group R2 or R3 to be bonded to a lower alkyl radical R1 or, if R2 or R3 represents, for example, hydroxy-lower alkyl, for this hydroxy-lower alkyl, together with the adjacent acyl radical Ac1 or Ac2, to form a 2-oxa-1-oxo-lower alkylene radical, the carbonyl group of which is bonded to the 3- or 5-ring carbon atom of the 1,4-dihydropyridine ring, and each of the groups Ac1 and Ac2  represents, independently of the other, the acyl radical of an acid, and salts of compounds of the formula I having salt-forming groups, processes for the manufacture of these compounds, the use of these compounds and their salts, and pharmaceutical preparations which contain these compounds and salts, as antihypertensive agents and coronary dilators for the treatment of cardiovascular conditions, such as hypertonia, vascular constrictions, Angina pectoris and cardiac insufficiency.
Patent ES-548067-A0 (ES)
IPC: A61K31/40
Filed: 1985-10-21
Abstract: 1-(fluoro- or perfluoro lower alkyl-substituted benzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid carboxymethyl ester is found to have antiinflammatory and analgestic activity with less side effects on gastrointestinal traces than its homologue, acemetacin or indometacin.
Patent ES-555139-A0 (ES)
IPC: F16G13/07
Filed: 1986-05-20
Abstract: An elongated link chain includes a plurality of hingedly connected chain links. Each chain link is made of punched out sheet metal defining a first plane, and includes two lateral walls extending in the longitudinal direction of the chain and spaced from one another in a direction transverse to the longitudinal direction. At least one transverse web in the first plane rigidly interconnects the lateral walls for holding the walls in position with respect to one another. Each lateral wall includes an arm, and each arm has an end portion constituting a bearing pin. Each lateral wall has a separate bearing hole punched-out in the sheet metal for receiving the respective associated bearing pin of another identical chain link which is arranged adjacently to the bearing holes; the separate bearing holes are made coaxial with one another by bending the lateral walls in a direction approximately at right angles to the first plane, so as to extend in a second plane, and to constitute an approximately U-shaped bracket with the transverse web, in which the bearing holes are spaced at an axial distance from one another. The bearing holes define a first axis, and the parts of respective end portions of the bearing pins define a second axis, which axes are parallel to one another. The bearing pins are bent back so that at least parts of respective end portions extend in a direction approximately parallel to that of the transverse web.
Patent FI-842321-A0 (FI)
Inventor: PRINS FOKKO
IPC: B62B1/22
Filed: 1984-06-08
Abstract: A wheel barrow comprising a carrier frame (1), a travelling wheel (2) at one end, connected to said carrier frame by coupling means for movably carrying said carrier frame, a pair of handles (15, 16) at the other end for manually supporting and wheeling the barrow, and cargo accommodated means for holding and transporting cargo. According to the invention, said cargo accommodating means include a lifting clamp (5) comprising a pair of clamping jaws (7, 8).
Patent FI-845106-A0 (FI)
Inventor: BREWERTON ROBERT WALTER
IPC: B63B35/44
Filed: 1984-12-21
Abstract: A compensator for providing resilience in a connection between relatively moveable objects comprises a piston (3) working in a cylinder (2) which is surrounded by a larger coaxial cylinder (1) joined thereto by annular wall members (1a) thus defining about the cylinder (2) a pair of annular reservoirs (8, 9,) The piston (3) divides the cylinder (2) into a pair of chambers (6, 7), chamber (6) being connected by conduit (12) to reservoir (9) and chamber (7) being connected by conduit (10) to reservoir (8). Each reservoir contains a mixture of liquid and gas whilst the chambers contain liquid. Elongation of the connection between the objects causes withdrawal of the piston (3) with consequent expansion of the volume of gas in reservoir (9) against atmospheric pressure and against pressure developed in reservoir (8) as a consequence of decrease of gas volume therein.
Patent FI-871105-A0 (FI)
Inventor: SHELAR GARY ROGER
IPC: A24F42/60
Filed: 1987-03-13
Abstract: The present invention relates to a smoking article which has the appearance of a conventional pipe. The pipe of the present invention is capable of producing substantial quantities of aerosol, preferably without significant thermal degradation of the aerosol former and without the presence of substantial pyrolysis or incomplete combustion products. These and other advantages are obtained by providing a pipe (10) which includes a disposable cartridge (18) containing a short, i.e., less than about 30 mm long, preferably carbonaceous, fuel element (20), a physically separate aerosol generating means (24) including an aerosol forming substance, and means for retaining the cartridge within the pipe bowl.
Patent FI-893226-A0 (FI)
Inventor: SATO YOSHINARI
IPC: C07D403/12
Filed: 1989-07-03
Abstract: A compound of the formula : <CHEM>  wherein R<1> is halogen, heterocyclic group which may have one or more suitable substituent(s), aryl which may have one or more suitable substituent(s), -NH-R<5> (in which R<5> is hydrogen, lower alkanoyl or hydroxy(lower)alkyl), -S-R<6> (in which R<6> is lower alkyl, lower alkyl substituted with carboxy and amino, lower alkyl substituted with protected carboxy and protected amino, or pyridyl), -O-R<7> (in which R<7> is hydrogen, hydroxy protective group, lower alkyl, lower alkenyl, ar(lower)alkyl, halo(lower)alkyl, amino(loweralkyl, protected amino(lower)alkyl, or piperazinyl(lower)alkyl which may have lower alkyl), -CONH-R<8> (in which R<8> is cyano, carbamoyl(lower)alkyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl, or lower alkyl substituted with carbamoyl and aryl ), or  -Z-R<9> [in which R<9> is hydrogen or lower alkyl, and Z is <CHEM>  (wherein is hydroxy, lower alkoxy or amino) or <CHEM> (wherein R<1><1> is carboxy or protected carboxy and R<1><2> is hydrogen; or R<1><1> is halogen and R<1><2> is halogen)],  R<2> is aryl which may have one or more suitable substituent(s),  R<3> is hydrogen or halogen,  R<4> is hydrogen, halogen or lower alkoxy and  A is lower alkylene,  and a pharmaceutically acceptable salt thereof, processes for the preparation and pharmaceutical compositions comprising them as an active ingredient
Patent FI-893299-A0 (FI)
Inventor: HEURTAULT SERGE
IPC: B22D11/06
Filed: 1989-07-06
Abstract: Method of continuous casting thin metallic products such as sheets or strips, according to which the molten metal is brought into contact with the cooled wall of a main roll (1) driven in rotation, the liquid metal (7) additionally being contained by a roller (3) of smaller diameter than that of the roll, which is driven in rotation and maintained at a distance from the wall of the main roll with a value substantially equal to the thickness of the cast product (10). 
<??>The roller (3) is driven in rotation at a greater peripheral speed than that of the roll (1). 
<??>The installation for carrying out the method comprises means (4, 5) for driving in rotation the roller (3) at a speed which is adjustable independently of the speed of the main roll. 
<IMAGE>
Patent FI-895554-A0 (FI)
Inventor: LENK ROBERT P
IPC: A61K31/5575
Filed: 1989-11-21
Abstract: A liposome composition and methods for making same are disclosed, such compositions comprise an arachidonic acid metabolite such as a prostaglandin, preferably prostaglandin E1, a lipid, and a drying protectant such as a saccharide. The liposomes may be loaded with prostaglandin passively, or using a transmembrane concentration gradient, preferably using a transmembrane pH gradient. Using this transmembrane loading technique, trapping efficiencies of 50% to 100% are achieved, and the release rate of the prostaglandin from the liposomes is reduced. The liposome size is maintained after lyophilization and reconstitution.
Patent FI-895694-A0 (FI)
Inventor: BORDUNOV VLADIMIR VASILIEVICH
IPC: C23G5/00
Filed: 1989-11-28
Abstract: PCT No. PCT/SU88/00075 Sec. 371 Date Dec. 4, 1989 Sec. 102(e) Date Dec. 4, 1989 PCT Filed Mar. 29, 1988 PCT Pub. No. WO89/09099 PCT Pub. Date Oct. 5, 1989.The proposed method resides in that the surface of a workpiece is treated with a molten solvent which at first is crystallized at the surface of the workpiece and then is melted to result in a used solution which is cooled and settled to form two layers, viz., an upper layer containing petroleum products, light mechanical impurities and a quantity of the solvent, and a lower layer containing the solvent, heafy mechanical impurities and a quantity of petroleum products, after which petroleum products are separated from the upper layer, whereas, the crystals of the solvent are melted and added to the lower layer from which the solvent is separated and conveyed for cleaning the workpieces. An apparatus for carrying out the method comprises a system (12) for regenerating the used solution connected to a system (20) for separating constituents of the upper layer (18), and a system (21) for separating constituents of the lower layer (19).
Patent FI-910412-A0 (FI)
Inventor: CABRI WALTER
IPC: C07H15/252
Filed: 1991-01-28
Abstract: 4-substituted anthracyclinones of formula (I) <CHEM> wherein R represents a hydrogen atom or a straight or branched alkyl, alkenyl or alkynyl group having from 1 to 10 carbon atoms, are intermediates in the preparation of antitumor anthracycline glycosides of formula (IX): <CHEM> wherein R is as defined above and R1 is a hydrogen atom or a hydroxy group, and pharmaceutically acceptable salts thereof.
Patent FI-915260-A0 (FI)
Inventor: FRANCKE KURT
IPC: A47K13/00
Filed: 1991-11-07
Abstract: An arrangement for detachably holding seats (2) to the bowls of water-flushed toilets and comprising a number of arms (10) which can be adjustably attached to the underside of the seat (2). The free outer ends of the arms (10) are provided with pins (11) which can be locked in positions against the outside of the bowl rim of the toilet when the seat (2) is placed in position on the bowl. The arms (10) are pivotally mounted and can be locked in selected positions. The pins (11) are provided with a sleeve (12) of rubber or plastic material which generates a fricfional force in contact with the toilet bowl. The arms (10) pivot around a screw (19) which is screwed into the underside of the toilet seat (2) and which in one position enables the arm (10) to be adjusted positionally and in another position locks the arm. The head (20) of the screw (19) is preferably covered with a coating (23) of rubber or plastic material and forms a cushion which rests on the toilet bowl when the toilet seat (2) is in its position of use. <IMAGE>
Patent FI-924676-A0 (FI)
Inventor: WANG KARLY S
IPC: A61K9/70
Filed: 1992-10-15
Abstract: An in-line adhesive, useful for transdermal delivery devices comprising a mixture of high and low molecular weighted polyisobutylene having a ratio HMW PIB:LMW PIB in the range of about 5-40:95-60 which is substantially free of plasticizers and tackifiers is disclosed. The adhesive finds particular use as a component of a transdermal delivery device for delivering oily non-polar agents such as nicotine, benztropine, secoverine, dexsecoverine, and arecoline.
Patent FI-942549-A0 (FI)
Inventor: MAYRAND LUC
IPC: H04W28/26
Filed: 1994-05-31
Abstract: A system for allocating communication channels within a cellular radio system in which each channel seizure request is assigned a call type based upon the capabilities of the mobile station, the nature of the call and the characteristics of the subscriber. A first algorithm is used to select a communication channel group for the call and a second algorithm is used to select an available communication channel from within the selected channel group.
Patent FI-944134-A0 (FI)
Inventor: TOWNSEND LEROY B
IPC: C07D235/26
Filed: 1994-09-08
Abstract: Antiviral nucleoside analogues contain a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue. Particularly preferred compounds include those in which the 2-, 5- and 6- positions of the benzimidazole base are substituted by halogen. The compounds have activity against herpes virus especially cytomegalovirus and also hepatitis B virus infections.
Patent FI-944341-A0 (FI)
IPC: D21B1/32
Filed: 1994-09-19
Abstract: A method and apparatus for reclaiming cellulosic fibers from a bale containing waste papers, in which the bale is positioned in a treatment enclosure, and the enclosure is placed under a vacuum. A treating fluid is drawn into the enclosure, which penetrates the bale interior spaces, and produces a preferential swelling-of uncontaminated cellulosic fibers. After the treating fluid is withdrawn from the enclosure, a slurrying fluid is passed through the bale contents, to form a fiber-fluid suspension slurry.
Patent FI-945215-A0 (FI)
Inventor: AKETA TOMOYUKI
IPC: C08K5/527
Filed: 1994-11-04
Abstract: In a blended resin composition comprising a general polyester and a liquid crystal polyester resin, the liquid crystal polyester resin is fibrillated in the molding step to obtain a resin composition having excellent mechanical strength etc. The present invention relates to a synthetic resin composition comprising 100 parts by weight of a resin component composed of 99 to 50 parts by weight of a polyester resin (a) not forming an anisotropic melt phase and 1 to 50 parts by weight of a liquid crystal polyester resin (b) capable of forming an anisotropic melt phase as well as 0.01 to 0.5 parts by weight of a phosphorus compound (c), said liquid crystal polyester resin (b) capable of forming an anisotropic melt phase is fibrillated to an aspect ratio of 6 or more in the molding step.
Patent FI-955730-A0 (FI)
Inventor: ILLUM LISBETH
IPC: A61K9/22
Filed: 1995-11-28
Abstract: The invention provides an oral drug delivery composition comprising an  alpha  -adreno receptor blocking drug characterised in that the composition is adapted to release a first portion of the drug in the upper gastrointestinal tract and to release a second portion of the drug by sustained release in the terminal ileum and/or the colon. This composition provides a two phase release profile which maintains sufficient and steady plasma levels for therapeutic effect whilst minimising side effects by avoiding a high peak in plasma levels. The sustained release of the second and optionally the first portion of the drug is achieved by a controlled release system such as a hydrophilic gel matrix. The specific release of the second portion of the drug in the colon can be achieved by coating tablets containing the second portion with a pH or redox sensitive coating such as a polymethylmethacrylate.
Patent FI-964921-A0 (FI)
Inventor: TANKOVICH I NIKOLAI
IPC: A45D26/00
Filed: 1996-12-09
Abstract: The present invention provides an apparatus for the removal of epidermal skin cells of corneum stratum on a section of human skin, the apparatus including :   a) a light absorbing contaminant capable of infiltrating into the corneum stratum cells when applied to the skin and having a high absorption at at least one frequeny band of light ; and b) an illumination source in spaced apart relation to the contaminant when applied to a section of human skin for illuminating a surface of the section of human skin and the contaminant with pulses of light having sufficient energy to cause the tearing off of the superficial epidermal skin cells of corneum stratum.   <IMAGE>
Patent FI-973163-A0 (FI)
Inventor: ABERG GUNNAR
IPC: A61K31/215
Filed: 1997-07-30
Abstract: A method for treating urinary incontinence while avoiding concomitant liability of adverse effects associated with racemic oxybutynin is disclosed. The method comprises administering a therapeutically effective amount of (S)-oxybutynin, (S)-desethyloxybutynin or a pharmaceutically acceptable salt thereof, substantially free of the corresponding R enantiomer. Pharmaceutical compositions in the form of tablets and transdermal devices comprising (S)-oxybutynin or (S)-desethyloxybutynin and an acceptable carrier are also disclosed, as is a synthesis of desethyloxybutynin.
Patent IL-67058-A0 (IL)
Title: Production of cupric hydroxide
IPC: C01G3/02
Filed: 1982-10-25
Abstract: In a process of producing cupric hydroxides, products having a high stability in storage will be obtained if phosphate ions are added to a suspension of copper oxychloride in an aqueous phase, the copper oxychloride is then reacted with alkali metal hydroxide or alkaline earth metal hydroxide, and the cupric hydroxide precipitated as a result of the suspension is washed and then re-suspended and subsequently stabilized by the addition of acid phosphate to adjust a pH value of 7.5 to 9. The suspended copper oxychloride is preferably reacted in the presence of phosphate ions in an amount of 1 to 4 grams per liter of the suspension and at a temperature of 20 DEG  to 25 DEG  C. and the resulting cupric hydroxide is stabilized with phosphate ions in an amount of 3 to 6 grams per liter of the suspension.
Patent IL-68318-A0 (IL)
Title: Imidazoline derivatives,process for their preparation and pharmaceutical preparations containing the same
IPC: A61P9/00
Filed: 1983-04-07
Abstract: Imidazoline derivatives of the formulahaving the RS or S configuration wherein R<sup>1</sup> is alkyl C<sub>1-4</sub>, allyl, benzyl, phenethyl or hydroxyalkyl C<sub>2-4</sub>, and their non-toxic salts.Processes for their preparation and pharmaceutical compositions thereof. The compounds exhibit presynaptic a<sub>2</sub>-adrenoreceptor antagonist activity.
Patent IL-92563-A0 (IL)
Title: Plug connection
IPC: A61C8/00
Filed: 1989-12-06
Abstract: A plug-in connection for releasably mounting a prosthesis or the like on the fixing head of a dowel crown post (10) or the like, having a plug part which is provided on the fixing head and has a circumferential constriction (12) in a plane lying substantially perpendicular to the longitudinal axis of symmetry of the fixing head, a base part (17) which carries the prosthesis, and a resilient clamping ring (20) engaging behind the constriction of the plug part and producing a positive connection between the latter and the base part, the base part being resiliently mounted in relation to the plug part in respect of impact stresses occurring substantially in the direction of the longitudinal axis of symmetry of the fixing head. The plug part has a cylindrical under-part (12) adjoining the dowel crown post and a mushroom-shaped upper part (14) adjacent thereto whose external diameter is largest close to the end of the under-part which is remote from the dowel crown post, where it exceeds the external diameter of the under-part and its generated surface extends substantially conically from the region of maximum diameter to a flattened point (16) of the upper part; the base part has in the region of the constriction an annular recess (18) which partially receives the resilient clamping ring (20); and a mounting ring (22) of resilient plastic and/or rubber material is arranged between the conical generated surface of the upper part and the base part.
Patent IL-94081-A0 (IL)
Title: Soluble interferon-gamma receptors,their production and pharmaceutical compositions comprising them
IPC: A61K38/00
Filed: 1990-04-13
Abstract: The present invention relates to soluble IFN- gamma receptors, to DNA sequences coding for these soluble IFN- gamma receptors and methods for making these.
Patent IL-98285-A0 (IL)
Title: Gas-recirculating electrode for electrochemical system
IPC: H01M12/08
Filed: 1991-05-27
Abstract: An electrode apparatus for use in an electrochemical cell, which permits hydrogen gas generated at the cathode to be recirculated directly to the anode. The electrode apparatus comprises:   a. an ion-permeable membrane (10) separating the anode compartment (12) and cathode compartment (14) and liquids contained therein; b. hydrogen electrodes, cathode (16) and anode (18), in their respective compartments (12 and 14) and in contact with the membrane (10), each comprising a porous hydrophobic catalytic structure which permits the passage of hydrogen gas both along and perpendicular to the longitudinal surface (20 and 26) of the electrode (12 and 14) and having an external portion (24 and 30) extending outside of the electrode compartment (12 and 14) and exposing the edge surface (22 and 28) of the electrode; and c. a gas chamber (32) connected to the external portions (24 and 30) of the electrodes and providing for transfer of gas from the cathode (18) directly to the anode (16).   Hydrogen gas generated at the cathode (18) passes through the cathode and along the length (26) thereof to the edge surface (28) thereof, into the gas chamber (32), and then to the edge surface (22) of the anode and along and through the length (20) of the anode (16). Thus, hydrogen gas from the cathode (18) is recirculated to replenish hydrogen consumed at the anode (16) during operation of the electrochemical cell. <IMAGE>